NORAH TIO: Open Payments
NPI 1902596745 · HANOVER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $303 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 3 | $167 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ABBVIE INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Braeburn Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: SUBLOCADE, Auvelity, FANAPT, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, BRIXADI, ARISTADA.
Industry payments across MD — which companies pay providers there.
